Guidelines for the management of chronic cough in adults. Endorsed by the French speaking society of respiratory diseases (Société de Pneumologie de Langue Française, SPLF), the Société Française d'Oto-Rhino-Laryngologie et de Chirurgie de la Face et du Cou (SFORL), the Société Française de Phoniatrie et de Laryngologie (SFPL), the Société Nationale Française de Gastro-entérologie (SNFGE)
Copyright © 2023 SPLF and Elsevier Masson SAS. All rights reserved..
Patients with chronic cough experience a high alteration of quality of life. Moreover, chronic cough is a complex entity with numerous etiologies and treatments. In order to help clinicians involved in the management of patients with chronic cough, guidelines on chronic cough have been established by a group of French experts. These guidelines address the definitions of chronic cough and the initial management of patients with chronic cough. We present herein second-line tests that might be considered in patients with cough persistence despite initial management. Experts also propose a definition of unexplained or refractory chronic cough (URCC) in order to better identify patients whose cough persists despite optimal management. Finally, these guidelines address the pharmacological and non-pharmacological interventions useful in URCC. Thus, amitryptilline, pregabalin, gabapentin or morphine combined with speech and/or physical therapy are a mainstay of treatment strategies in URCC. Other treatment options, such as P2 × 3 antagonists, are being developed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
Respiratory medicine and research - 83(2023) vom: 05. Juni, Seite 101011 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Guilleminault, Laurent [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic cough |
|---|
| Anmerkungen: |
Date Completed 09.06.2023 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.resmer.2023.101011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355916282 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355916282 | ||
| 003 | DE-627 | ||
| 005 | 20231226065346.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.resmer.2023.101011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1186.xml |
| 035 | |a (DE-627)NLM355916282 | ||
| 035 | |a (NLM)37087905 | ||
| 035 | |a (PII)S2590-0412(23)00023-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Guilleminault, Laurent |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Guidelines for the management of chronic cough in adults. Endorsed by the French speaking society of respiratory diseases (Société de Pneumologie de Langue Française, SPLF), the Société Française d'Oto-Rhino-Laryngologie et de Chirurgie de la Face et du Cou (SFORL), the Société Française de Phoniatrie et de Laryngologie (SFPL), the Société Nationale Française de Gastro-entérologie (SNFGE) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.06.2023 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 SPLF and Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Patients with chronic cough experience a high alteration of quality of life. Moreover, chronic cough is a complex entity with numerous etiologies and treatments. In order to help clinicians involved in the management of patients with chronic cough, guidelines on chronic cough have been established by a group of French experts. These guidelines address the definitions of chronic cough and the initial management of patients with chronic cough. We present herein second-line tests that might be considered in patients with cough persistence despite initial management. Experts also propose a definition of unexplained or refractory chronic cough (URCC) in order to better identify patients whose cough persists despite optimal management. Finally, these guidelines address the pharmacological and non-pharmacological interventions useful in URCC. Thus, amitryptilline, pregabalin, gabapentin or morphine combined with speech and/or physical therapy are a mainstay of treatment strategies in URCC. Other treatment options, such as P2 × 3 antagonists, are being developed | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chronic cough | |
| 650 | 4 | |a Hypersensitivity | |
| 650 | 4 | |a Neuromodulators | |
| 700 | 1 | |a Demoulin-Alexikova, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a de Gabory, Ludovic |e verfasserin |4 aut | |
| 700 | 1 | |a Varannes, Stanislas Bruley Des |e verfasserin |4 aut | |
| 700 | 1 | |a Brouquières, Danielle |e verfasserin |4 aut | |
| 700 | 1 | |a Balaguer, Mathieu |e verfasserin |4 aut | |
| 700 | 1 | |a Chapron, Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Grassin-Delyle, Stanislas |e verfasserin |4 aut | |
| 700 | 1 | |a Poussel, Mathias |e verfasserin |4 aut | |
| 700 | 1 | |a Guibert, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Reychler, Grégory |e verfasserin |4 aut | |
| 700 | 1 | |a Trzepizur, Wojciech |e verfasserin |4 aut | |
| 700 | 1 | |a Woisard, Virginie |e verfasserin |4 aut | |
| 700 | 1 | |a Crestani, Sabine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiratory medicine and research |d 2019 |g 83(2023) vom: 05. Juni, Seite 101011 |w (DE-627)NLM298429772 |x 2590-0412 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2023 |g day:05 |g month:06 |g pages:101011 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.resmer.2023.101011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2023 |b 05 |c 06 |h 101011 | ||